Model-dependent transport limitations shape the in vitro evaluation of platinum-based nanotherapeutics.

Authors

Chiara Vitale, Maria Elisabetta F Palamà, Arianna Fedi, Michele Iafisco, Alessandra Barbanente, Nicola Margiotta, Lorenzo Degli Esposti, Roberta Castriconi, Maurizio Aiello, Silvia Scaglione

Published in

Nanomedicine : nanotechnology, biology, and medicine. Pages 103043. Oct 20, 2026. Epub Oct 20, 2026.

Abstract

Platinum-based chemotherapeutics remain central in oncology but are limited by systemic toxicity and poor tumor selectivity. Here, we investigate hydroxyapatite nanoparticles (HA NPs) as carriers for Pt(II) complexes, and compare the activity of free and NP-conjugated formulations across 2D cultures, static 3D tumor models, and flow-conditioned 3D systems using identical formulations, doses, and biological endpoints. Static 3D models impose diffusion-driven constraints that limit NP penetration, promote peripheral accumulation, and attenuate the apparent efficacy of NP-conjugated formulations. In contrast, quantitative spatial fluorescence profiling show that dynamic flow conditions partially alleviate these limitations, enhancing distal NP distribution and therapeutic activity. Notably, these transport-dependent effects influence the relative performance of free and nano-formulated drugs across models. Overall, our findings demonstrate that transport limitations in static systems can distort nanomedicine evaluation, highlighting the importance of incorporating flow-controlled conditions in preclinical screening.

PMID:
42901458
Bibliographic data and abstract were imported from PubMed on 21 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.